HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rafael Alvarez Selected Research

Therapeutics

8/2023Sex Differences in Glomerular Lesions, in Atherosclerosis Progression, and in the Response to Angiotensin-Converting Enzyme Inhibitors in the ApoE-/- Mice Model.
2/2020A rodent model of partial intestinal diversion: a novel metabolic operation.
1/2020The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
12/2019Factors Associated With Long Wait Times for Bariatric Surgery.
5/2017Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rafael Alvarez Research Topics

Disease

6Neoplasms (Cancer)
01/2021 - 08/2009
4Weight Loss (Weight Reduction)
01/2023 - 01/2020
3Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 01/2017
2Gastroesophageal Reflux (GERD)
01/2023 - 01/2023
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 05/2017
2Adenocarcinoma
01/2018 - 12/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2015 - 07/2009
2Venous Thromboembolism
04/2015 - 05/2014
2Alzheimer Disease (Alzheimer's Disease)
02/2015 - 01/2015
1Cardiovascular Diseases (Cardiovascular Disease)
08/2023
1Proteinuria
08/2023
1Inflammation (Inflammations)
08/2023
1Hypertrophy
08/2023
1Chronic Renal Insufficiency
08/2023
1Atherosclerosis
08/2023
1Hypoxia (Hypoxemia)
01/2021
1Urticaria (Hives)
12/2020
1Hypersensitivity (Allergy)
12/2020
1Insulin Resistance
02/2020
1Obesity
02/2020
1Edema (Dropsy)
01/2020
1Hypertension (High Blood Pressure)
01/2020
1Leukocytosis (Pleocytosis)
01/2020
1Disease Progression
01/2020
1Morbid Obesity
12/2019
1Breast Neoplasms (Breast Cancer)
11/2018
1Femoral Neck Fractures
05/2018
1Adult Form Polyglucosan Body Disease
01/2018
1Late Onset Disorders
01/2018
1Clinical Deterioration
05/2017
1Lung Neoplasms (Lung Cancer)
08/2015
1Pneumonia (Pneumonitis)
05/2014
1Blindness (Hysterical Blindness)
02/2002
1Acidosis
02/2002
1Poisoning
02/2002

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2017
3LipidsIBA
01/2021 - 08/2015
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2017
2PlatinumIBA
01/2021 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
02/2020 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
05/2017 - 08/2009
2Fatty Acids (Saturated Fatty Acids)IBA
08/2015 - 08/2009
1CreatinineIBA
08/2023
1EnalaprilFDA LinkGeneric
08/2023
1LDL CholesterolIBA
08/2023
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2023
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2023
1Apolipoproteins E (ApoE)IBA
08/2023
1Docosahexaenoic AcidsIBA
01/2021
1docosapentaenoic acidIBA
01/2021
1prostaglandin E3 (PGE3)IBA
01/2021
1AcidsIBA
01/2021
1CalciumIBA
01/2021
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2021
1Eicosapentaenoic AcidIBA
01/2021
1Dinoprostone (PGE2)FDA Link
01/2021
1alpha-Linolenic Acid (Linolenic Acid)IBA
01/2021
1AllergensIBA
12/2020
1Insulin (Novolin)FDA Link
02/2020
1salicylhydroxamic acid (SHAM)IBA
02/2020
1Bevacizumab (Avastin)FDA Link
01/2020
1ElectrolytesIBA
01/2020
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020
1vanucizumabIBA
01/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020
1Anti-Anxiety Agents (Anxiolytics)IBA
01/2020
1Hormones (Hormone)IBA
11/2018
11,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA
01/2018
1GuaiacolIBA
01/2018
1polyglucosanIBA
01/2018
1130-nm albumin-bound paclitaxelIBA
12/2017
1GemcitabineFDA Link
12/2017
1Cetuximab (Erbitux)FDA Link
05/2017
1Cell-Free Nucleic AcidsIBA
05/2017
1MicroRNAs (MicroRNA)IBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1TrioleinIBA
08/2015
1Triglycerides (Triacylglycerol)IBA
08/2015
1Olive OilIBA
08/2015
1Protein Kinases (Protein Kinase)IBA
08/2015
1Mitogen-Activated Protein Kinase 3IBA
08/2015
1hydroxytrioleinIBA
08/2015
1AlkaloidsIBA
02/2015
1AcetylcholinesteraseIBA
01/2015
14-hexyloxyaniline (HOA)IBA
08/2009
1Methanol (Carbinol)IBA
02/2002

Therapy/Procedure

5Therapeutics
08/2023 - 05/2017
5Bariatric Surgery
01/2023 - 12/2019
5Drug Therapy (Chemotherapy)
01/2023 - 01/2017
4Gastrectomy
01/2023 - 01/2020
2Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2023 - 01/2020
1Osteotomy
05/2018
1Neoadjuvant Therapy
12/2017
1Early Ambulation
04/2015
1Chemoprevention
05/2014
1Critical Care (Surgical Intensive Care)
05/2014
1Adjuvant Chemotherapy
07/2009
1Renal Dialysis (Hemodialysis)
02/2002